NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

泡殼包裝醫藥品市場:全球產業分析、市場規模、佔有率、成長、趨勢、預測 (2020 - 2030年)

Blister Pack Pharmaceutical Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

出版商 Transparency Market Research 商品編碼 980281
出版日期 內容資訊 英文 170 Pages
商品交期: 最快1-2個工作天內
價格
泡殼包裝醫藥品市場:全球產業分析、市場規模、佔有率、成長、趨勢、預測 (2020 - 2030年) Blister Pack Pharmaceutical Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
出版日期: 2020年12月03日內容資訊: 英文 170 Pages
簡介

本報告提供全球泡殼包裝醫藥品市場相關調查,全球市場概要,價值鏈等相關資訊,加上COVID-19市場給予的影響,各市場區隔、各地區/國家的市場分析,主要企業的簡介。

目錄

第1章 摘要整理

  • 市場概要
  • 市場分析
  • TMR的分析與建議
  • 市場機會分析

第2章 市場簡介

  • 市場區隔
  • 市場分類

第3章 市場見解

  • 全球經濟的展望
  • 全球醫藥品市場概要
  • 宏觀經濟要素和相互關係分析
  • 預測要素:相關性及影響
  • 價值鏈分析

第4章 COVID-19的影響

  • 目前統計和預計的未來的影響
  • 目前經濟預測:GDP/GVA與預計的影響
  • SAAR與市場復甦比較:主要國家
  • 2008年的金融危機與市場復甦的比較:主要國家
  • COVID-19對泡殼包裝醫藥品市場的影響

第5章 泡殼包裝醫藥品市場分析

  • 市場規模 (以金額為準) 及分析&預測
  • 與前一年同期比較成長預測
  • 機會分析

第6章 全球泡殼包裝醫藥品市場規模分析、預測 :各藥物類型

  • 章節的摘要
  • 簡介
    • 市場佔有率&基點(BPS)分析:各藥物類型
    • 與前一年同期比較成長預測:各藥物類型
  • 市場規模成果分析:各藥物類型
    • 片劑
    • 膠囊
  • 市場規模的預測:各藥物類型
    • 片劑
    • 膠囊
  • 市場魅力分析:各藥物類型

第7章 全球泡殼包裝醫藥品市場分析、預測:各製造流程

  • 章節概要
  • 簡介
    • 市場佔有率&基點(BPS)分析:各製造流程
    • 與前一年同期比較成長預測:各製造流程
  • 市場規模成果分析:各製造流程
    • 冷間成型
    • 熱成型
  • 市場規模的預測:各製造流程
    • 冷間成型
    • 熱成型
  • 市場魅力分析:各製造流程

第8章 全球泡殼包裝醫藥品市場分析、預測:各最終用途

  • 章節概要
  • 簡介
    • 市場佔有率&基點(BPS)分析:各最終用途
    • 與前一年同期比較成長預測:各最終用途
  • 市場規模成果分析:各最終用途
    • 醫藥品
    • 營養補充品和補充品
    • 動物用醫藥品
  • 市場規模成果分析:各最終用途
    • 醫藥品
    • 營養補充品和補充品
    • 動物用醫藥品
  • 市場魅力分析:按最終用途

第9章 全球泡殼包裝醫藥品市場分析、預測:各地區

  • 章節概要
  • 簡介
    • 市場佔有率&基點(BPS)分析:各地區
    • 與前一年同期比較成長預測:各地區
  • 市場規模成果分析:各地區
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東、非洲(中東、非洲)
  • 市場規模的預測:各地區
    • 北美
    • 南美
    • 歐洲
    • 亞太地區
    • 中東、非洲(中東、非洲)
  • 市場魅力分析:各地區

第10章 北美的泡殼包裝醫藥品市場分析與預測

  • 章節概要
  • 簡介
    • 市場佔有率&基點(BPS)分析:各國
    • 與前一年同期比較成長預測:各國
  • 市場規模成果分析:各國
  • 市場規模的預測:各國
    • 美國
    • 加拿大
  • 市場規模成果分析:各藥物類型
  • 市場規模的預測:各藥物類型
    • 片劑
    • 膠囊
  • 市場規模成果分析:各製造流程
  • 市場規模的預測:各製造流程
    • 冷間成型
    • 熱成型
  • 市場規模成果分析:各最終用途
  • 市場規模成果分析:各最終用途
    • 醫藥品
    • 營養補充品和補充品
    • 動物用醫藥品
  • 顯著的趨勢

第11章 南美的泡殼包裝醫藥品市場分析與預測

第12章 歐洲的泡殼包裝醫藥品市場分析與預測

第13章 亞太地區的泡殼包裝醫藥品市場分析與預測

第14章 中東、非洲的泡殼包裝醫藥品市場分析與預測

第15章 市場結構分析

  • 市場分析:各企業等級
  • 市場集中度
  • 市場影響分析

第16章 競爭情形

  • 競爭儀表板
  • 企業的市場佔有率分析
  • 企業簡介概要(詳細內容-概要,財務,策略,最近的趨勢,SWOT分析)
  • 競爭Deep Dive

第17章 前提條件與縮寫

第18章 調查手法

目錄
Product Code: TMRGL80261

Title:
Blister Pack Pharmaceutical Products Market (Drug Type: Tablets and Capsules; Manufacturing Process: Cold Forming and Thermoforming; and End Use: Pharmaceuticals, Nutraceuticals and Supplements, and Veterinary Drugs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030.

Blister Pack Pharmaceutical Products Market - Scope of the Report

Transparency Market Research (TMR) started a new study on the global blister pack pharmaceutical products market, providing forecast for the period of 2020-2030. In the study, growth opportunity for the blister pack pharmaceutical products market is witnessed. The report provides valuable insights, which enable readers to make winning business decisions for future growth of their businesses. The report highlights significant factors that are constantly determining the growth of the blister pack pharmaceutical products market, untapped opportunities for manufacturers, trends and developments, and other insights across various key segments. Macroeconomic factors that are directly or indirectly affecting market growth are also incorporated in the report.

Key Questions Answered in TMR's Blister Pack Pharmaceutical Products Market Report

What will be market size for blister pack pharmaceutical products by the end of 2030?

What will be the impact of COVID-19 on blister pack pharmaceutical products market?

Which is the most preferred manufacturing process for packaging of blister packed pharmaceutical products in the global market?

Which region will remain most lucrative for market growth?

Which end use segment holds maximum market share of the global blister pack pharmaceutical products market?

Who are major key players in the blister pack pharmaceutical products market?

Key indicators associated with the blister pack pharmaceutical products market have been calculated thoroughly in the report. The study enumerates vital market dynamics such as key drivers, challenges, and trends, along with opportunities in the global blister pack pharmaceutical products market. A comprehensive study on the value chain, which includes component suppliers, manufacturers, distributors, and end users have been incorporated in the global market report. Other key aspects laid down in the market include pricing strategy of leading market players and comparative analysis of blister pack pharmaceutical products. Furthermore, forecast factors and forecast scenarios of the blister pack pharmaceutical products market have been covered in the report to understand future prospects of the market.

A comprehensive evaluation and forecast on the blister pack pharmaceutical products market are provided on the drug type, manufacturing process, end use, and region.

Y-o-Y growth comparison, revenue comparison, and market share comparison of various market segments are provided in the report. The blister pack pharmaceutical products market is analyzed at both regional and country levels.

The report delivers an exhaustive assessment on the structure of the blister pack pharmaceutical products market, in tandem with a dashboard view of all leading company profiles in the report. Every company's share analysis on market players have also been presented in the report, apart from the footprint matrix of profiled market players. The report depicts the presence of blister pack pharmaceutical products manufacturers by leveraging an intensity map. It also highlights key end users for blister pack pharmaceutical products.

The report includes company overview of key players. Some of the key companies profiled in the blister pack pharmaceutical products market report include Pfizer Inc, GlaxoSmithKline plc, Sanofi, Roche Holding AG, Novartis AG, Allergan, Johnson & Johnson, Merck, Sun Pharmaceutical Industries Ltd, Cadila Healthcare, etc.

Research Methodology

A realistic methodology, along with a holistic approach makes the base for sharp insights, which are provided in the blister pack pharmaceutical products market for the study evaluation period. The TMR report comprises of detailed information on growth prospects, along with riveting insights into the forecast assessment of the market.

Extensive primary and secondary researches have been employed to garner keen insights into the forecast study of the blister pack pharmaceutical products market. The report has further undergone a cross-validation by in-house professionals to make the blister pack pharmaceutical products market report one-of-its-kind with the highest credibility.

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. TMR Analysis and Recommendations
  • 1.4. Opportunity Analysis

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Market Viewpoint

  • 3.1. Global Economic Outlook
  • 3.2. Global Pharmaceutical Market Overview
  • 3.3. Macro-Economic Factors and Co-relation Analysis
  • 3.4. Forecast Factors - Relevance and Impact
  • 3.5. Value Chain Analysis
    • 3.5.1. Exhaustive List of Active Participants
      • 3.5.1.1. Raw Material Suppliers
      • 3.5.1.2. Manufacturers
      • 3.5.1.3. Distributers/End Users
    • 3.5.2. Profitability Margins

4. Impact of COVID-19

    • 4.1.1. Current Statistics and Probable Future Impact
    • 4.1.2. Current Economic Projection - GDP/GVA and Probable Impact
    • 4.1.3. Comparison of SAARs and Market Recovery, for Key Countries
    • 4.1.4. Comparison to 2008 Financial Crisis and Market Recovery, for Key Countries
    • 4.1.5. Impact of COVID-19 on Blister Pack Pharmaceutical Products Market

5. Blister Pack Pharmaceutical Products Market Analysis

  • 5.1. Market Value (US$ Mn) and Analysis & Forecast
  • 5.2. Y-o-Y Growth Projections
  • 5.3. Absolute $ Opportunity Analysis

6. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Drug Type

  • 6.1. Section Summary
  • 6.2. Introduction
    • 6.2.1. Market share and Basis Points (BPS) Analysis By Drug Type
    • 6.2.2. Y-o-Y Growth Projections By Drug Type
  • 6.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
    • 6.3.1. Tablets
    • 6.3.2. Capsules
  • 6.4. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
    • 6.4.1. Tablets
    • 6.4.2. Capsules
  • 6.5. Market Attractiveness Analysis By Drug Type

7. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By Manufacturing Process

  • 7.1. Section Summary
  • 7.2. Introduction
    • 7.2.1. Market share and Basis Points (BPS) Analysis By Manufacturing Process
    • 7.2.2. Y-o-Y Growth Projections By Manufacturing Process
  • 7.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
    • 7.3.1. Cold Forming
    • 7.3.2. Thermoforming
  • 7.4. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
    • 7.4.1. Cold Forming
    • 7.4.2. Thermoforming
  • 7.5. Market Attractiveness Analysis By Manufacturing Process

8. Global Blister Pack Pharmaceutical Products Analysis and Forecast, By End Use

  • 8.1. Section Summary
  • 8.2. Introduction
    • 8.2.1. Market share and Basis Points (BPS) Analysis By End Use
    • 8.2.2. Y-o-Y Growth Projections End Use
  • 8.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
    • 8.3.1. Pharmaceuticals
    • 8.3.2. Nutraceuticals and Supplements
    • 8.3.3. Veterinary Drugs
  • 8.4. Market Size (US$ Mn) Forecast 2020-2030, By End Use
    • 8.4.1. Pharmaceuticals
    • 8.4.2. Nutraceuticals and Supplements
    • 8.4.3. Veterinary Drugs
  • 8.5. Market Attractiveness Analysis By End Use

9. Global Blister Pack Pharmaceutical Products Market Analysis and Forecast, By Region

  • 9.1. Section Summary
  • 9.2. Introduction
    • 9.2.1. Market share and Basis Points (BPS) Analysis By Region
    • 9.2.2. Y-o-Y Growth Projections By Region
  • 9.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Region
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. Middle East and Africa (MEA)
  • 9.4. Market Size (US$ Mn) Forecast 2020-2030 By Region
    • 9.4.1. North America
    • 9.4.2. Latin America
    • 9.4.3. Europe
    • 9.4.4. Asia Pacific
    • 9.4.5. Middle East and Africa (MEA)
  • 9.5. Market Attractiveness Analysis By Region

10. North America Blister Pack Pharmaceutical Products Market Analysis and Forecast

  • 10.1. Section Summary
  • 10.2. Introduction
    • 10.2.1. Market share and Basis Points (BPS) Analysis By Country
    • 10.2.2. Y-o-Y Growth Projections By Country
  • 10.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
  • 10.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
    • 10.4.1. U.S.
    • 10.4.2. Canada
  • 10.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
  • 10.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
    • 10.6.1. Tablets
    • 10.6.2. Capsules
  • 10.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
  • 10.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
    • 10.8.1. Cold Forming
    • 10.8.2. Thermoforming
  • 10.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
  • 10.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
    • 10.10.1. Pharmaceuticals
    • 10.10.2. Nutraceuticals and Supplements
    • 10.10.3. Veterinary Drugs
  • 10.11. Prominent Trends

11. Latin America Blister Pack Pharmaceutical Products Market Analysis and Forecast

  • 11.1. Section Summary
  • 11.2. Introduction
    • 11.2.1. Market share and Basis Points (BPS) Analysis By Country
    • 11.2.2. Y-o-Y Growth Projections By Country
  • 11.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
  • 11.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Argentina
    • 11.4.4. Rest of Latin America
  • 11.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
  • 11.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
    • 11.6.1. Tablets
    • 11.6.2. Capsules
  • 11.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
  • 11.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
    • 11.8.1. Cold Forming
    • 11.8.2. Thermoforming
  • 11.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
  • 11.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
    • 11.10.1. Pharmaceuticals
    • 11.10.2. Nutraceuticals and Supplements
    • 11.10.3. Veterinary Drugs
  • 11.11. Prominent Trends

12. Europe Blister Pack Pharmaceutical Products Market Analysis and Forecast

  • 12.1. Section Summary
  • 12.2. Introduction
    • 12.2.1. Market share and Basis Points (BPS) Analysis By Country
    • 12.2.2. Y-o-Y Growth Projections By Country
  • 12.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
  • 12.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
    • 12.4.1. Germany
    • 12.4.2. Spain
    • 12.4.3. Italy
    • 12.4.4. France
    • 12.4.5. U.K.
    • 12.4.6. BENELUX
    • 12.4.7. NORDIC
    • 12.4.8. Russia
    • 12.4.9. Poland
    • 12.4.10. Rest of Europe
  • 12.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
  • 12.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
    • 12.6.1. Tablets
    • 12.6.2. Capsules
  • 12.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
  • 12.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
    • 12.8.1. Cold Forming
    • 12.8.2. Thermoforming
  • 12.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
  • 12.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
    • 12.10.1. Pharmaceuticals
    • 12.10.2. Nutraceuticals and Supplements
    • 12.10.3. Veterinary Drugs
  • 12.11. Prominent Trends

13. Asia Pacific Blister Pack Pharmaceutical Products Market Analysis and Forecast

  • 13.1. Section Summary
  • 13.2. Introduction
    • 13.2.1. Market share and Basis Points (BPS) Analysis By Country
    • 13.2.2. Y-o-Y Growth Projections By Country
  • 13.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
  • 13.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
    • 13.4.1. China
    • 13.4.2. India
    • 13.4.3. Japan
    • 13.4.4. ASEAN
    • 13.4.5. Australia and New Zealand
    • 13.4.6. Rest of APAC
  • 13.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
  • 13.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
    • 13.6.1. Tablets
    • 13.6.2. Capsules
  • 13.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
  • 13.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
    • 13.8.1. Cold Forming
    • 13.8.2. Thermoforming
  • 13.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
  • 13.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
    • 13.10.1. Pharmaceuticals
    • 13.10.2. Nutraceuticals and Supplements
    • 13.10.3. Veterinary Drugs
  • 13.11. Prominent Trends

14. Middle East and Africa Blister Pack Pharmaceutical Products Market Analysis and Forecast

  • 14.1. Section Summary
  • 14.2. Introduction
    • 14.2.1. Market share and Basis Points (BPS) Analysis By Country
    • 14.2.2. Y-o-Y Growth Projections By Country
  • 14.3. Historical Market Size (US$ Mn) Analysis 2015-2019 By Country
  • 14.4. Market Size (US$ Mn) Forecast 2020-2030 By Country
    • 14.4.1. GCC countries
    • 14.4.2. Northern Africa
    • 14.4.3. South Africa
    • 14.4.4. Turkey
    • 14.4.5. Rest of MEA
  • 14.5. Historical Market Size (US$ Mn) Analysis 2015-2019 By Drug Type
  • 14.6. Market Size (US$ Mn) Forecast 2020-2030, By Drug Type
    • 14.6.1. Tablets
    • 14.6.2. Capsules
  • 14.7. Historical Market Size (US$ Mn) Analysis 2015-2019 By Manufacturing Process
  • 14.8. Market Size (US$ Mn) Forecast 2020-2030, By Manufacturing Process
    • 14.8.1. Cold Forming
    • 14.8.2. Thermoforming
  • 14.9. Historical Market Size (US$ Mn) Analysis 2015-2019 By End Use
  • 14.10. Market Size (US$ Mn) Forecast 2020-2030, By End Use
    • 14.10.1. Pharmaceuticals
    • 14.10.2. Nutraceuticals and Supplements
    • 14.10.3. Veterinary Drugs
  • 14.11. Prominent Trends

15. Market Structure Analysis

  • 15.1. Market Analysis, by Tier of Companies
  • 15.2. Market Concentration
  • 15.3. Market Presence Analysis

16. Competitive Landscape

  • 16.1. Competition Dashboard
  • 16.2. Company Market Share Analysis
  • 16.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments, SWOT analysis)
  • 16.4. Competition Deep Dive
      • 16.4.1.1. Pfizer Inc
        • 16.4.1.1.1. Overview
        • 16.4.1.1.2. Product Portfolio
        • 16.4.1.1.3. Profitability
        • 16.4.1.1.4. Sales Footprint
        • 16.4.1.1.5. Competition Benchmarking
        • 16.4.1.1.6. Strategy
        • 16.4.1.1.6.1. Marketing Strategy
        • 16.4.1.1.6.2. Product Strategy
        • 16.4.1.1.6.3. Channel Strategy
      • 16.4.1.2. GlaxoSmithKline plc
        • 16.4.1.2.1. Overview
        • 16.4.1.2.2. Product Portfolio
        • 16.4.1.2.3. Profitability
        • 16.4.1.2.4. Sales Footprint
        • 16.4.1.2.5. Competition Benchmarking
        • 16.4.1.2.6. Strategy
        • 16.4.1.2.6.1. Marketing Strategy
        • 16.4.1.2.6.2. Product Strategy
        • 16.4.1.2.6.3. Channel Strategy
      • 16.4.1.3. Sanofi
        • 16.4.1.3.1. Overview
        • 16.4.1.3.2. Product Portfolio
        • 16.4.1.3.3. Profitability
        • 16.4.1.3.4. Sales Footprint
        • 16.4.1.3.5. Competition Benchmarking
        • 16.4.1.3.6. Strategy
        • 16.4.1.3.6.1. Marketing Strategy
        • 16.4.1.3.6.2. Product Strategy
        • 16.4.1.3.6.3. Channel Strategy
      • 16.4.1.4. Roche Holding AG
        • 16.4.1.4.1. Overview
        • 16.4.1.4.2. Product Portfolio
        • 16.4.1.4.3. Profitability
        • 16.4.1.4.4. Sales Footprint
        • 16.4.1.4.5. Competition Benchmarking
        • 16.4.1.4.6. Strategy
        • 16.4.1.4.6.1. Marketing Strategy
        • 16.4.1.4.6.2. Product Strategy
        • 16.4.1.4.6.3. Channel Strategy
      • 16.4.1.5. Novartis AG
        • 16.4.1.5.1. Overview
        • 16.4.1.5.2. Product Portfolio
        • 16.4.1.5.3. Profitability
        • 16.4.1.5.4. Sales Footprint
        • 16.4.1.5.5. Competition Benchmarking
        • 16.4.1.5.6. Strategy
        • 16.4.1.5.6.1. Marketing Strategy
        • 16.4.1.5.6.2. Product Strategy
        • 16.4.1.5.6.3. Channel Strategy
      • 16.4.1.6. Allergan
        • 16.4.1.6.1. Overview
        • 16.4.1.6.2. Product Portfolio
        • 16.4.1.6.3. Profitability
        • 16.4.1.6.4. Sales Footprint
        • 16.4.1.6.5. Competition Benchmarking
        • 16.4.1.6.6. Strategy
        • 16.4.1.6.6.1. Marketing Strategy
        • 16.4.1.6.6.2. Product Strategy
        • 16.4.1.6.6.3. Channel Strategy
      • 16.4.1.7. Johnson & Johnson
        • 16.4.1.7.1. Overview
        • 16.4.1.7.2. Product Portfolio
        • 16.4.1.7.3. Profitability
        • 16.4.1.7.4. Sales Footprint
        • 16.4.1.7.5. Competition Benchmarking
        • 16.4.1.7.6. Strategy
        • 16.4.1.7.6.1. Marketing Strategy
        • 16.4.1.7.6.2. Product Strategy
        • 16.4.1.7.6.3. Channel Strategy
      • 16.4.1.8. Merck
        • 16.4.1.8.1. Overview
        • 16.4.1.8.2. Product Portfolio
        • 16.4.1.8.3. Profitability
        • 16.4.1.8.4. Sales Footprint
        • 16.4.1.8.5. Competition Benchmarking
        • 16.4.1.8.6. Strategy
        • 16.4.1.8.6.1. Marketing Strategy
        • 16.4.1.8.6.2. Product Strategy
        • 16.4.1.8.6.3. Channel Strategy
      • 16.4.1.9. Sun Pharmaceutical Industries Ltd
        • 16.4.1.9.1. Overview
        • 16.4.1.9.2. Product Portfolio
        • 16.4.1.9.3. Profitability
        • 16.4.1.9.4. Sales Footprint
        • 16.4.1.9.5. Competition Benchmarking
        • 16.4.1.9.6. Strategy
        • 16.4.1.9.6.1. Marketing Strategy
        • 16.4.1.9.6.2. Product Strategy
        • 16.4.1.9.6.3. Channel Strategy
      • 16.4.1.10. Cadila Healthcare
        • 16.4.1.10.1. Overview
        • 16.4.1.10.2. Product Portfolio
        • 16.4.1.10.3. Profitability
        • 16.4.1.10.4. Sales Footprint
        • 16.4.1.10.5. Competition Benchmarking
        • 16.4.1.10.6. Strategy
        • 16.4.1.10.6.1. Marketing Strategy
        • 16.4.1.10.6.2. Product Strategy
        • 16.4.1.10.6.3. Channel Strategy

17. Assumptions and Acronyms

18. Research Methodology

List of Tables

  • Table 01: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
  • Table 02: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
  • Table 03: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
  • Table 04: Global Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Region
  • Table 05: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
  • Table 06: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
  • Table 07: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
  • Table 08: North America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
  • Table 09: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
  • Table 10: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
  • Table 11: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
  • Table 12: Latin America Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
  • Table 13: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
  • Table 14: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
  • Table 15: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
  • Table 16: Europe Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
  • Table 17: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
  • Table 18: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
  • Table 19: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
  • Table 20: Asia Pacific Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country
  • Table 21: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Drug Type
  • Table 22: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Manufacturing Process
  • Table 23: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by End Use
  • Table 24: MEA Blister Pack Pharmaceutical Products Market Value (US$ Bn) 2015H-2030F, by Country value (US$ Bn) 2015H-2030F, by Drug Type

List of Figures

  • Figure 01: Global Blister Pack Pharmaceutical Products Market Share by Drug Type (2020E & 2030F)
  • Figure 02: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Drug Type, 2020E-2028F
  • Figure 03: Global Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
  • Figure 04: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
  • Figure 05: Global Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
  • Figure 06: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
  • Figure 07: Global Blister Pack Pharmaceutical Products Market Share by Region (2020E & 2030F)
  • Figure 08: Global Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Region, 2020E-2028F
  • Figure 09: North America Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
  • Figure 10: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
  • Figure 11: North America Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
  • Figure 12: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
  • Figure 13: North America Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
  • Figure 14: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
  • Figure 15: North America Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
  • Figure 16: North America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
  • Figure 17: Latin America Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
  • Figure 18: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
  • Figure 19: Latin America Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
  • Figure 20: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
  • Figure 21: Latin America Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
  • Figure 22: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
  • Figure 23: Latin America Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
  • Figure 24: Latin America Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
  • Figure 25: Europe Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
  • Figure 26: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
  • Figure 27: Europe Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
  • Figure 28: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
  • Figure 29: Europe Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
  • Figure 30: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
  • Figure 31: Europe Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
  • Figure 32: Europe Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
  • Figure 33: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
  • Figure 34: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
  • Figure 35: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
  • Figure 36: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
  • Figure 37: Asia Pacific Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
  • Figure 38: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
  • Figure 39: Asia Pacific Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
  • Figure 40: Asia Pacific Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F
  • Figure 41: MEA Blister Pack Pharmaceutical Products Market Share by Product Type (2020E & 2030F)
  • Figure 42: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Product Type, 2020E-2028F
  • Figure 43: MEA Blister Pack Pharmaceutical Products Market Share by Manufacturing Process (2020E & 2030F)
  • Figure 44: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Manufacturing Process, 2020E-2028F
  • Figure 45: MEA Blister Pack Pharmaceutical Products Market Share by End Use (2020E & 2030F)
  • Figure 46: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by End Use, 2020E-2028F
  • Figure 47: MEA Blister Pack Pharmaceutical Products Market Share by Country (2020E & 2030F)
  • Figure 48: MEA Blister Pack Pharmaceutical Products Market Attractiveness Analysis, by Country, 2020E-2028F